Is high thromboembolic risk not really associated with low time in therapeutic range in patients with prosthetic heart valves?

Abstract

Dear Editor, We have recently read with great interest the article reported by Poli et al. which was published in the last issue of International Journal of Cardiology [1]. We appreciate the authors for valuable contribution to the literature, however, we believe that there are several major drawbacks that need to be addressed.